• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值并预测肝细胞癌的新治疗药物。

Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.

作者信息

Han Cuifang, Chen Jiaru, Huang Jing, Zhu Riting, Zeng Jincheng, Yu Hongbing, He Zhiwei

机构信息

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China.

School of Pharmacy, Guangdong Medical University, Dongguan, China.

出版信息

Front Oncol. 2023 Mar 8;13:1162375. doi: 10.3389/fonc.2023.1162375. eCollection 2023.

DOI:10.3389/fonc.2023.1162375
PMID:36969048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10032208/
Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1104262.].

摘要

[本文更正了文章DOI：10.3389/fonc.2023.1104262。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d0/10032208/95f5ab45d000/fonc-13-1162375-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d0/10032208/5b242bbe938c/fonc-13-1162375-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d0/10032208/95f5ab45d000/fonc-13-1162375-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d0/10032208/5b242bbe938c/fonc-13-1162375-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d0/10032208/95f5ab45d000/fonc-13-1162375-g007.jpg

相似文献

1
Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.勘误：单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值并预测肝细胞癌的新治疗药物。
Front Oncol. 2023 Mar 8;13:1162375. doi: 10.3389/fonc.2023.1162375. eCollection 2023.
2
Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值，并预测肝细胞癌的新型治疗药物。
Front Oncol. 2023 Jan 31;13:1104262. doi: 10.3389/fonc.2023.1104262. eCollection 2023.
3
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.勘误：ASPM是一种预后生物标志物，与肾透明细胞癌和肝细胞癌中的免疫浸润相关。
Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.
4
Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.勘误：脂肪酸合酶在人类肝细胞癌中的发病机制、预后及治疗作用
Front Oncol. 2022 Apr 12;12:874053. doi: 10.3389/fonc.2022.874053. eCollection 2022.
5
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.勘误：CDT1是一种用于肝细胞癌的新型预后和预测生物标志物。
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
6
Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.勘误：Nectin-1高表达提示肝细胞癌预后不良并促进转移。
Front Oncol. 2023 Mar 21;13:1134139. doi: 10.3389/fonc.2023.1134139. eCollection 2023.
7
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis regulating the arachidonic acid metabolism.勘误：OIT3通过介导铁死亡调节花生四烯酸代谢，作为肝细胞癌的一种新型生物标志物。
Front Oncol. 2022 Oct 26;12:1038279. doi: 10.3389/fonc.2022.1038279. eCollection 2022.
8
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.勘误：与原发性胆汁酸生物合成及肝细胞癌肿瘤微环境相关的线粒体相关预后生物标志物的鉴定。
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
9
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
10
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.勘误：上调的LINC01667表达与肝细胞癌的不良预后相关。
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.